You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
生物股份(600201.SH):遼寧益康的雞馬立克氏病活疫苗(rMDV-MS-△meq株)獲得獸藥產品批准文號批件
格隆匯 05-24 17:21

格隆匯5月24日丨生物股份(600201.SH)公佈,根據《獸藥管理條例》《獸藥產品批准文號管理辦法》等有關規定,經農業農村部審查,准予金宇生物技術股份有限公司控股子公司遼寧益康生物股份有限公司(簡稱“遼寧益康”)生產雞馬立克氏病活疫苗(rMDV-MS-△meq株),並核發獸藥產品批准文號。

上述獸藥產品於2017年1月獲得新獸藥臨牀試驗批件,經臨牀試驗後,遼寧益康與聯合開發單位共同開展新獸藥證書註冊相關工作,並於2021年6月29日獲得新獸藥註冊證書。截至目前,該產品累計研發投入金額約639萬元(未含工藝優化投入金額)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account